BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8263554)

  • 21. Concurrent zidovudine-induced myopathy and hepatoxicity in patients treated for human immunodeficiency virus (HIV) infection.
    Chen SC; Barker SM; Mitchell DH; Stevens SM; O'Neill P; Cunningham AL
    Pathology; 1992 Apr; 24(2):109-11. PubMed ID: 1641255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant granulocyte colony-stimulating factor (rG-CSF) in HIV patients with zidovudine related neutropenia.
    Clumeck N; Wit SD; Hermans P; Franchioly P; Sommereijns B
    J Nutr Sci Vitaminol (Tokyo); 1992; Spec No():353-6. PubMed ID: 1284305
    [No Abstract]   [Full Text] [Related]  

  • 23. Exacerbation of HIV-associated myopathy by zidovudine.
    Berger JR; Shebert R; Gregorios JB
    AIDS; 1991 Feb; 5(2):229-30. PubMed ID: 2031699
    [No Abstract]   [Full Text] [Related]  

  • 24. Zidovudine and other drugs against HIV.
    Drug Ther Bull; 1988 Dec; 26(26):101-4. PubMed ID: 3065024
    [No Abstract]   [Full Text] [Related]  

  • 25. Myopathy in human immunodeficiency virus-infected children receiving long-term zidovudine therapy.
    Walter EB; Drucker RP; McKinney RE; Wilfert CM
    J Pediatr; 1991 Jul; 119(1 Pt 1):152-5. PubMed ID: 1906098
    [No Abstract]   [Full Text] [Related]  

  • 26. Cytochrome c oxidase reaction improves histopathological assessment of zidovudine myopathy.
    Chariot P; Monnet I; Gherardi R
    Ann Neurol; 1993 Oct; 34(4):561-5. PubMed ID: 8215243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Zidovudine myopathy: a distinctive disorder associated with mitochondrial dysfunction.
    Mhiri C; Baudrimont M; Bonne G; Geny C; Degoul F; Marsac C; Roullet E; Gherardi R
    Ann Neurol; 1991 Jun; 29(6):606-14. PubMed ID: 1892364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of granulocyte colony-stimulating factor (G-CSF) on neutropenia in zidovudine-treated patients with AIDS and ARC: a preliminary report.
    Garavelli PL
    Haematologica; 1992; 77(3):293-4. PubMed ID: 1385275
    [No Abstract]   [Full Text] [Related]  

  • 29. Zidovudine treatment of patients with acquired immune deficiency syndrome and acquired immune deficiency syndrome-related complex: long-term experience.
    Smiley L
    J Infect; 1989 Jan; 18 Suppl 1():77. PubMed ID: 2644363
    [No Abstract]   [Full Text] [Related]  

  • 30. Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.
    Schröder JM; Bertram M; Schnabel R; Pfaff U
    Acta Neuropathol; 1992; 85(1):39-47. PubMed ID: 1285495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex.
    Glaser JB; Volpe S; Aguirre A; Simpkins H; Schiffman G
    J Infect Dis; 1991 Oct; 164(4):761-4. PubMed ID: 1894937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
    Swanson CE; Tindall B; Cooper DA
    AIDS; 1994 May; 8(5):625-34. PubMed ID: 8060543
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group.
    Fischl MA; Richman DD; Causey DM; Grieco MH; Bryson Y; Mildvan D; Laskin OL; Groopman JE; Volberding PA; Schooley RT
    JAMA; 1989 Nov; 262(17):2405-10. PubMed ID: 2677429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AZT myopathy and HIV-1 polymyositis: one disease or two?
    Walsh K; Kaye K; Demaerschalk B; Stewart S; Crukley J; Hammond R
    Can J Neurol Sci; 2002 Nov; 29(4):390-3. PubMed ID: 12463497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute meningo-encephalitis on dose reduction of zidovudine.
    Helbert M; Robinson D; Peddle B; Forster S; Kocsis A; Jeffries D; Pinching AJ
    Lancet; 1988 Jun; 1(8597):1249-52. PubMed ID: 2897518
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Zidovudine-induced myopathy: A study in Indian patients.
    Sagar A; Mohanty AP; Bahal A
    J Neurosci Rural Pract; 2010 Jul; 1(2):63-6. PubMed ID: 21808505
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of HIV infection with zidovudine. The good use of AZT].
    Régnier B
    Rev Prat; 1991 Sep; 41(19):1801-4. PubMed ID: 1925359
    [No Abstract]   [Full Text] [Related]  

  • 38. [Long-term success with zidovudine in HIV infection].
    Leber Magen Darm; 1989 May; 19(3):158. PubMed ID: 2500573
    [No Abstract]   [Full Text] [Related]  

  • 39. Skeletal muscle involvement in HIV-infected patients.
    Gherardi RK
    Neuropathol Appl Neurobiol; 1994 Jun; 20(3):232-7. PubMed ID: 7936072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternating and intermittent regimens of zidovudine and dideoxycytidine in patients with AIDS or AIDS-related complex.
    Skowron G; Bozzette SA; Lim L; Pettinelli CB; Schaumburg HH; Arezzo J; Fischl MA; Powderly WG; Gocke DJ; Richman DD; Pottage JC; Antoniskis D; McKinley GF; Hyslop NE; Ray G; Simon G; Reed N; LoFaro ML; Uttamchandani RB; Gelb LD; Sperber SJ; Murphy RL; Leedom JM; Grieco MH; Zachary J; Hirsch MS; Spector SA; Bigley J; Soo W; Merigan TC
    Ann Intern Med; 1993 Mar; 118(5):321-30. PubMed ID: 8094279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.